USPTO trademark

DUHUNTTYX

AllowedUSPTOWord markClass 5

"DUHUNTTYX" is a word mark owned by Skyhawk Therapeutics, Inc., filed at the USPTO on March 5, 2026. It has been allowed and covers class 5 (Pharmaceuticals).

Official USPTO record
DUHUNTTYX trademark as filed
As filed with the USPTO
Status
Allowed
Since September 8, 2026
Filed
March 5, 2026
Registered
Not yet
Expires
Not recorded
Application no.
99684307
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns DUHUNTTYX

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services DUHUNTTYX is filed for, grouped by Nice class.

  • Pharmaceuticals, namely, small molecule therapeutic preparations for the correction of RNA expression and alteration of RNA translation, used in the treatment of Huntington’s Disease

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Noa e-mailed - sou required from applicant
  2. Official gazette publication confirmation e-mailed
  3. Published for opposition
  4. Notification of notice of publication e-mailed
  5. Approved for pub - principal register
  6. Assigned to examiner
  7. New application office supplied data entered
  8. Application filing receipt mailed
  9. New application entered
FAQ

About DUHUNTTYX

Who owns the trademark "DUHUNTTYX"?

The USPTO trademark "DUHUNTTYX" (application 99684307) is owned by Skyhawk Therapeutics, Inc.

What is the status of "DUHUNTTYX"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull DUHUNTTYX and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019d3ec4-6c9f-75e8-9852-ef223e6aa57a
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d3ec4-6c9f-75e8-9852-ef223e6aa57a",
  "object": "trademark",
  "mark_text": "DUHUNTTYX",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "99684307",
  "filing_date": "2026-03-05",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Skyhawk Therapeutics, Inc.",
      "entity_id": "ent_01a10cf0-67bd-75cf-9fd3-71754e0fe49f"
    }
  ]
}